Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Observational Study of Daptomycin in the Treatment of Gram-positive Bacterial Infections

NCT04546815 is registered in ClinicalTrials.gov with Jiangsu Hengrui Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT04546815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04546815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Observational Study of Daptomycin in the Treatment of Gram-positive Bacterial Infections
Lead sponsor
Jiangsu Hengrui Pharmaceutical Co., Ltd.
Phase
Observational
Overall status
Unknown status
Start date
August 25, 2020
Completion date
August 31, 2022
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic